timolol has been researched along with Glaucoma, Neovascular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chistyakov, TA; Kuzmin, AG; Lipatov, DV; Tolkacheva, AA | 1 |
| Townsend-Pico, W; Yoshizumi, MO | 1 |
2 other study(ies) available for timolol and Glaucoma, Neovascular
| Article | Year |
|---|---|
The fixed combination efficacy assessment in patients with secondary neovascular glaucoma and diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amides; Cloprostenol; Diabetic Angiopathies; Drug Combinations; Drug Substitution; Female; Glaucoma, Neovascular; Humans; Intraocular Pressure; Male; Middle Aged; Timolol; Treatment Outcome | 2015 |
Essential thrombocythemia and central retinal vein occlusion with neovascular glaucoma.
Topics: Adrenergic beta-Antagonists; Antisickling Agents; Aspirin; Bone Marrow; Fluorescein Angiography; Fundus Oculi; Glaucoma, Neovascular; Humans; Hydroxyurea; Intraocular Pressure; Laser Coagulation; Male; Middle Aged; Neovascularization, Pathologic; Optic Disk; Platelet Aggregation Inhibitors; Platelet Count; Retinal Vein Occlusion; Thrombocythemia, Essential; Timolol | 1996 |